Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SBTX Silverback Therapeutics

4.660
-0.060-1.27%
Close 09/23 16:00 ET
4.650
-0.010-0.21%
Post Mkt Price 09/23 16:01 ET
High
4.720
Open
4.600
Turnover
1.73M
Low
4.450
Pre Close
4.720
Volume
371.71K
Market Cap
165.31M
P/E(TTM)
Loss
52wk High
11.850
Shares
35.47M
P/E(Static)
Loss
52wk Low
2.800
Float Cap
104.70M
Bid/Ask %
-33.33%
Historical High
63.410
Shs Float
22.47M
Volume Ratio
1.85
Historical Low
2.800
Dividend TTM
--
Div Yield TTM
--
P/B
0.59
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.65%
Amplitude
5.72%
Avg Price
4.643
Lot Size
1
Float Cap
104.70M
Bid/Ask %
-33.33%
Historical High
63.410
Shs Float
22.47M
Volume Ratio
1.85
Historical Low
2.800
Dividend TTM
--
P/B
0.59
Dividend LFY
--
Turnover Ratio
1.65%
Amplitude
5.72%
Avg Price
4.643
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA.
CEO: Dr. Laura Shawver, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...